NovoCure Ltd — Director's Dealing 2018

Jan 31, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-01-29

Reporting Person: Longsworth Todd Christopher (General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-29	Ordinary Shares	M	11630	$6.72	Acquired	16628	Direct
2018-01-29	Ordinary Shares	S	11630	$24.00	Disposed	4998	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-29	Options to Buy Ordinary Shares	$6.72	M	11630	Disposed	2022-04-29	Ordinary Shares (82782)	Direct

Footnotes

F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth.

F2: Fully vested and exercisable as of the date hereof.